A detailed history of Quarry LP transactions in Haemonetics Corp stock. As of the latest transaction made, Quarry LP holds 471 shares of HAE stock, worth $37,585. This represents 0.01% of its overall portfolio holdings.

Number of Shares
471
Holding current value
$37,585
% of portfolio
0.01%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$81.24 - $97.37 $38,264 - $45,861
471 New
471 $39 Million
Q4 2023

Feb 14, 2024

SELL
$80.59 - $92.61 $10,073 - $11,576
-125 Reduced 79.62%
32 $2.74 Million
Q3 2023

Nov 14, 2023

SELL
$82.56 - $93.49 $35,253 - $39,920
-427 Reduced 73.12%
157 $14.1 Million
Q2 2023

Aug 14, 2023

BUY
$80.84 - $89.45 $34,195 - $37,837
423 Added 262.73%
584 $49.7 Million
Q1 2023

May 15, 2023

SELL
$72.75 - $90.6 $4,874 - $6,070
-67 Reduced 29.39%
161 $13.3 Million
Q4 2022

Feb 14, 2023

BUY
$73.85 - $86.14 $16,837 - $19,639
228 New
228 $17.9 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.1B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Quarry LP Portfolio

Follow Quarry LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quarry LP, based on Form 13F filings with the SEC.

News

Stay updated on Quarry LP with notifications on news.